Processa Pharmaceuticals PCSA
NASDAQ PCSA
$1.75 +0.02 (+1.45%)
As of: Oct 21, 2026 · 3:58 PM EDT

Processa Pharmaceuticals (PCSA) Current Deferred Tax Assets (2014 - 2016)

Updated

Processa Pharmaceuticals' Current Deferred Tax Assets came in at $5.07 million for Q4 2016, up 2.7% from $4.94 million a year earlier.

Analysis

Processa Pharmaceuticals (PCSA) Current Deferred Tax Assets (2014 - 2016) Analysis & Trends

  • Going back by year, Current Deferred Tax Assets was $4.94 million in FY2015 (+45.0%) and $3.41 million in FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Processa Pharmaceuticals 4.81 Mn -8.93 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 5.07 Mn
Dec 31, 2015 4.94 Mn
Dec 31, 2014 3.41 Mn
API Access

Processa Pharmaceuticals Current Deferred Tax Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-tax-assets&ticker=PCSA&period=max&api_key=YOUR_API_KEY